- Abstract
- 1. Introduction
- 2. Materials and Methods
- 2.1. Data set
- 2.2. Structural Alignment

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
목차 (Table of Contents)
참고문헌 (Reference)
1 SYBYL Software, "Version X 2.0."
2 D. W. Porter, "The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists" 24 : 3285-3290, 2014
3 S. Wold, "The collinearity problem in linear-regression- the partial least squares (PLS) approach to generalized inverses" 5 : 735-743, 1984
4 S. L. Traves, "Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2" 76 : 441-450, 2004
5 J. Reutershan, "Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced lung injury" 289 : L807-L815, 2005
6 W. Sippl, "Recent Advances in QSAR Studies: Methods and Applications" Springer 2010
7 Sathya Babu, "Pharmacophore Based Comparative Molecular Field Analysis of CRTh2 Antagonists" 기초과학연구원 8 (8): 89-98, 2015
8 P. M. Murphy, "Neutrophil receptors for interleukin-8 and related CXC chemokines" 34 : 311-318, 1997
9 G. Klebe, "Molecular similarity indices in a comparative analysis (CoMSIA)of drug molecules to correlate and predict their biological activity" 37 : 4130-4146, 1994
10 Thirumurthy Madhavan, "Modeling Aided Lead Design of FAK Inhibitors" 기초과학연구원 4 (4): 266-272, 2011
1 SYBYL Software, "Version X 2.0."
2 D. W. Porter, "The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists" 24 : 3285-3290, 2014
3 S. Wold, "The collinearity problem in linear-regression- the partial least squares (PLS) approach to generalized inverses" 5 : 735-743, 1984
4 S. L. Traves, "Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2" 76 : 441-450, 2004
5 J. Reutershan, "Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced lung injury" 289 : L807-L815, 2005
6 W. Sippl, "Recent Advances in QSAR Studies: Methods and Applications" Springer 2010
7 Sathya Babu, "Pharmacophore Based Comparative Molecular Field Analysis of CRTh2 Antagonists" 기초과학연구원 8 (8): 89-98, 2015
8 P. M. Murphy, "Neutrophil receptors for interleukin-8 and related CXC chemokines" 34 : 311-318, 1997
9 G. Klebe, "Molecular similarity indices in a comparative analysis (CoMSIA)of drug molecules to correlate and predict their biological activity" 37 : 4130-4146, 1994
10 Thirumurthy Madhavan, "Modeling Aided Lead Design of FAK Inhibitors" 기초과학연구원 4 (4): 266-272, 2011
11 P. Anderson, "Emerging therapies in cystic fibrosis" 4 : 177-185, 2010
12 E. H. Bel, "Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)" 2010
13 S. Wold, "Cross-validatory estimation of the number of components in factor and principal component model" 20 : 397-405, 1978
14 Sathya. B, "Comparative Molecular Field Analysis of Caspase-3 Inhibitors" 기초과학연구원 7 (7): 166-172, 2014
15 R. W. Chapman, "CXCR2 antagonists for the treatment of pulmonary disease" 212 : 55-68, 2009
16 K. J.Eash, "CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow" 120 : 2423-2431, 2010
17 R. A. Pauwels, "Burden and clinical features of chronic obstructive pulmonary disease (COPD)" 364 : 613-620, 2004
18 M. Uguccioni, "Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes" 25 : 64-68, 1995
19 Thirumurthy Madhavan, "3D-QSAR Studies of 3,5-disubstituted Quinolines Inhibitors of c-Jun N-terminal Kinase-3" 기초과학연구원 4 (4): 216-221, 2011
In silico Analysis of Natural Compounds as Modulators of Type I Collagen
Activated Rap1A Induces Osteoblastic Differentiation and Cell Adhesion
Homology Modelling of Urotension-2 Receptor (UTS2R) : Potential Target for Human Pharmacotherapy
학술지 이력
| 연월일 | 이력구분 | 이력상세 | 등재구분 |
|---|---|---|---|
| 2022 | 평가예정 | 신규평가 신청대상 (신규평가) | |
| 2021-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
| 2020-12-01 | 평가 | 등재후보로 하락 (재인증) | ![]() |
| 2017-01-01 | 평가 | 등재학술지 유지 (계속평가) | ![]() |
| 2013-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
| 2012-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
| 2010-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
| 기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
|---|---|---|---|
| 2016 | 0.45 | 0.45 | 0.35 |
| KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
| 0.28 | 0.25 | 0.24 | 0.05 |